Microplate Dx

Curated by Signal

Developer of a diagnostic test for drug-resistant infections

Life Sciences Technologymicroplatedx.com

Overview

Developer of a diagnostic test for drug-resistant infections. It offers a Rplate platform that combines hardware with data processing algorithms to perform rapid antibiotic susceptibility tests for urinary tract infections.

Key facts

Founded: 2017
Headquarters: Glasgow, United Kingdom
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Reti Health
Developer of AI-powered retinal hypertension screening devices
Life Sciences TechnologyLondon, United Kingdom
Consortium AI
Developer of small molecules for the treatment of rare diseases using AI platform
Life Sciences TechnologyLondon, United Kingdom
Softcell
Manufacturer of pH monitoring device
Life Sciences TechnologyEdinburgh, United Kingdom

About Microplate Dx

What does Microplate Dx do?

Developer of a diagnostic test for drug-resistant infections.

Where is Microplate Dx headquartered?

Microplate Dx is headquartered in Glasgow, United Kingdom.

When was Microplate Dx founded?

Microplate Dx was founded in 2017.

Which sector is Microplate Dx in?

Microplate Dx operates in Life Sciences Technology.

Who are Microplate Dx's competitors?

Companies similar to Microplate Dx include Reti Health, Consortium AI, and Softcell.